Joseph K. Belanoff
2016
In 2016, Joseph K. Belanoff earned a total compensation of $2.4M as Chief Executive Officer and President at Corcept Therapeutics, a 29% increase compared to previous year.
Compensation breakdown
| Bonus | $400,000 |
|---|---|
| Option Awards | $1,382,390 |
| Salary | $615,000 |
| Total | $2,397,390 |
Belanoff received $1.4M in option awards, accounting for 58% of the total pay in 2016.
Belanoff also received $400K in bonus and $615K in salary.
Rankings
In 2016, Joseph K. Belanoff's compensation ranked 4,102nd out of 14,075 executives tracked by ExecPay. In other words, Belanoff earned more than 70.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,102 out of 14,075 | 71st |
Division Manufacturing | 1,437 out of 5,489 | 74th |
Major group Chemicals And Allied Products | 436 out of 1,895 | 77th |
Industry group Drugs | 317 out of 1,538 | 79th |
Industry Pharmaceutical Preparations | 249 out of 1,176 | 79th |
Source: SEC filing on April 21, 2017.
Belanoff's colleagues
We found two more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2016.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019